SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0001140361-22-042457
Filing Date
2022-11-21
Accepted
2022-11-21 11:55:29
Documents
1
Effectiveness Date
2022-11-21

Document Format Files

Seq Description Document Type Size
1 S-8 POS brhc10044418_s8pos.htm S-8 POS 16516
  Complete submission text file 0001140361-22-042457.txt   17560
Mailing Address 4301 EMPEROR BOULEVARD SUITE 400 DURHAM NC 27703
Business Address 4301 EMPEROR BOULEVARD SUITE 400 DURHAM NC 27703 (919) 237-5300
AERIE PHARMACEUTICALS INC (Filer) CIK: 0001337553 (see all company filings)

IRS No.: 203109565 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-228247 | Film No.: 221404757
SIC: 2836 Biological Products, (No Diagnostic Substances)